Novel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid Polymers
Clinics in Liver Disease · 2023
DOI: 10.1016/j.cld.2023.05.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2023. Verfasst von Lung-Yi Mak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Clinical Medicine, Queen Mary Hospital, Pokfulam Road 102, Hong Kong, China; State Key Laboratory of Liver Research…. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B, Nucleic Acids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Currently approved treatment of patients with chronic hepatitis B infection is insufficient to achieve functional cure. Numerous new compounds are identified, and among many, capsid assembly modulators (CAMs) and nucleic acid polymers (NAPs) are 2 classes of virus-directing agents in clinical development. CAMs interfere with viral pregenomic RNA encapsidation and are effective in viral load reduction but have limited effects on hepatitis B surface antigen (HBsAg). NAPs prevent HBsAg release from hepatocytes and induce intracellular degradation, leading to potent suppression of serum HBsAg when combined with nucleoside analogues and pegylated interferon demonstrated by initial data, but awaiting further confirmation studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, School of Clinical Medicine, Queen Mary Hospital, Pokfulam Road 102, Hong Kong, China; State Key Laboratory of Liver Research, 7/F, HK Jockey Club Building of Interdisciplinary Research, 5 Sassoo…
- Department of Medicine, School of Clinical Medicine, Queen Mary Hospital, Pokfulam Road 102, Hong Kong, China.
Förderung
- Gilead Sciences
Zitieren
APA
Mak, L. Y., Hui, R. W., Seto, W. K., & Yuen, M. F. (2023). Novel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid Polymers. Clinics in Liver Disease. https://doi.org/10.1016/j.cld.2023.05.004
Vancouver
Mak LY, Hui RW, Seto WK, Yuen MF. Novel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid Polymers. Clinics in Liver Disease. 2023. doi:10.1016/j.cld.2023.05.004
BibTeX
@article{Mak2023,
author = {Mak, Lung-Yi and Hui, Rex Wan-Hin and Seto, Wai-Kay and Yuen, Man-Fung},
title = {Novel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid Polymers},
journal = {Clinics in Liver Disease},
year = {2023},
doi = {10.1016/j.cld.2023.05.004}
}
EUVIMED